Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: results of a meta-analysis.
about
Strategies to reduce hepatitis C virus recurrence after liver transplantationRole of liver transplantation in human immunodeficiency virus positive patientsCurrent status of immunosuppression in liver transplantationMicroRNA signature at the time of clinical HCV recurrence associates with aggressive fibrosis progression post-liver transplantation.Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy data.A comprehensive review of immunosuppression used for liver transplantation.Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes.Recurrent hepatitis C after liver transplantPost-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.Tacrolimus-based versus cyclosporine-based immunosuppression in hepatitis C virus-infected patients after liver transplantation: a meta-analysis and systematic review.Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients.Management of recurrent hepatitis C following liver transplantation.Antiviral treatment for hepatitis C virus infection after liver transplantation.The impact of sirolimus on hepatitis C recurrence after liver transplantation.Management of recurrent hepatitis C virus after liver transplantation.Liver transplantation in HCV/HIV positive patients.Cyclosporine as monotherapy for psoriasis in the setting of chronic HCV infection: a forgotten therapeutical optionPrevention of hepatitis C recurrence after liver transplantation: An update.Living-donor liver transplantation and hepatitis CRisk factors for hepatitis C recurrence after liver transplantation.Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation.Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection.Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients.Liver transplantation for liver disease caused by hepatitis C virus infection.Management of the liver transplant patient.Liver transplantation in human immunodeficiency virus-positive patients.Present state of immunosuppressive therapy in liver transplant recipients.Diabetes mellitus following liver transplantation in patients with hepatitis C virus: risks and consequences.Immunosuppression, liver injury and post-transplant HCV recurrence.Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation.Immunomodulating options for liver transplant patients.Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation.Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor.Recurrent HCV after liver transplantation-mechanisms, assessment and therapy.Hepatitis C-induced hepatocyte apoptosis following liver transplantation is enhanced by immunosuppressive agents.Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients.Effect of tacrolimus on survival in hepatitis C-infected patients after liver transplantation.Viral hepatitis in solid organ transplantation.Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: outcomes analysis of the UNOS/OPTN database.Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection.
P2860
Q22305418-9668F10C-64EF-465F-A576-7614F3D3FE6AQ26775931-7B3C3992-1533-405E-B0B9-1A287F67A82FQ27694591-9F715082-D7EE-4615-A43C-3D60DD5F91CAQ30456389-09319260-EDA3-4161-933B-89A2A1B23FE2Q30560759-E404722F-E687-446A-B8E8-DBACDC50C3E7Q33602527-357898E1-119C-46B5-9C26-0D58FFB83639Q33659942-E82F324B-F433-46F4-BCF1-303B0E61EC54Q34067825-374BC63A-80F5-45DD-BA84-765E8ADCB05CQ34093760-FDDDACD3-CF3E-44A4-B194-8AD6979A783BQ34150039-09538BF3-2750-4697-8306-B9599BA39BD5Q34168552-15F98FA3-6C0F-4807-9853-A93D2F71D74AQ34298333-463498F3-D205-4823-B407-2233CEEB8B1FQ34340293-4409699B-366E-4F73-ABA4-1BD018AD010CQ34522556-B36538D8-A778-4D1E-898E-BC0B0C004C8BQ34589655-594DEE16-AA97-4407-AFED-DA413FA11BFBQ34640985-5787BDE8-785D-4C80-8071-B58BEF1C747BQ36075071-5A02ACDA-B960-40CC-A72D-2AB3F0495E50Q36220172-64FF91EB-7F8E-4734-9FB6-48647FCDF201Q36587253-3784E930-491C-4E8F-9E44-777E9C2233B8Q36980754-6015A11D-5945-48F7-9BB4-7AA8F225132EQ37118828-4E908965-56DA-4620-BBA1-555B8AE3843FQ37343317-A0D9FC20-8866-43A2-A3BD-AEEA0BE31AC2Q37355472-57BF887F-5D72-47D1-8B45-9FB898900384Q37396780-CC0ADC35-709C-41BA-9F99-C75B4A2E4461Q37636100-6F0FCF76-15A1-4E04-84B5-16C2E0AA2D6EQ37874569-4CC0A0E4-CDA4-4F4E-B1C5-7A4EA00CBDD3Q37919421-72286E51-F038-481C-A0BF-8FFC59FDF73FQ37962197-451E5C81-067D-4AEC-BBC3-D073D9581422Q37970381-D87F5C3F-C70B-4B17-B2F3-265CFC30A933Q37973516-D4C302BF-F8FA-4725-9BAE-44DB09F124DCQ38044761-7F78F9FA-8AD8-4686-AC1D-3A99B5A45591Q38053172-0432D4F3-5F89-4C4C-88A6-289B34D4F3EAQ38081919-9AC31AD3-A442-4264-A222-5C126088B99BQ38229320-5594FCBA-9202-46BD-A165-EB6CD77D0B4AQ40679311-C9212F22-1B48-46DF-A1A1-8B8709E37F05Q41888593-4AC8B9FA-1BB4-4A7C-88FF-569AF27A12AFQ42028499-9C13917F-1805-4409-9A94-9C7175EC2E90Q42272319-1057FFAF-96F4-4CB0-8983-D15E11745CA0Q42600645-3825D25C-4DC4-4A7C-B476-2B73A66DAE60Q42978531-CA24C021-80F3-4CB1-884F-D6821BB98C1F
P2860
Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: results of a meta-analysis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Immunosuppression with calcine ...... n: results of a meta-analysis.
@ast
Immunosuppression with calcine ...... n: results of a meta-analysis.
@en
type
label
Immunosuppression with calcine ...... n: results of a meta-analysis.
@ast
Immunosuppression with calcine ...... n: results of a meta-analysis.
@en
prefLabel
Immunosuppression with calcine ...... n: results of a meta-analysis.
@ast
Immunosuppression with calcine ...... n: results of a meta-analysis.
@en
P2860
P356
P1476
Immunosuppression with calcine ...... on: results of a meta-analysis
@en
P2093
Ana Royuela
Marina Berenguer
P2860
P356
10.1002/LT.21035
P577
2007-01-01T00:00:00Z